Graves Ophthalmopathy - Pipeline Review, H2 Pharmaceutical 2016
"Graves Ophthalmopathy - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves' Ophthalmopathy Pipeline Review, H2 2016, provides an overview of the Graves' Ophthalmopathy (Ophthalmology) pipeline landscape. Graves ophthalmopathy is an autoimmune condition where the thyroid gland mistakenly senses harmful cells and releases antibodies to combat them. Since there are no harmful cells, the released antibodies end up fusing with muscles in the eyes, causing the onset of Gravesophthalmopathy. Symptoms include eye redness, eye inflammation, eyelid retraction and eye weakness. Treatment includes radioiodine therapy, anti-thyroid medications and thyroid surgery. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=901113 R